Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-25-000825
Filing Date
2025-05-13
Accepted
2025-05-13 08:22:40
Documents
48
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q artl_10q.htm   iXBRL 10-Q 819539
2 CERTIFICATION artl_ex311.htm EX-31.1 9399
3 CERTIFICATION artl_ex321.htm EX-32.1 3749
  Complete submission text file 0001640334-25-000825.txt   3312637

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA artl-20250331.xsd EX-101.SCH 28979
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE artl-20250331_lab.xml EX-101.LAB 202125
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE artl-20250331_cal.xml EX-101.CAL 33901
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE artl-20250331_pre.xml EX-101.PRE 169052
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE artl-20250331_def.xml EX-101.DEF 90393
51 EXTRACTED XBRL INSTANCE DOCUMENT artl_10q_htm.xml XML 361939
Mailing Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075 858-925-7049
ARTELO BIOSCIENCES, INC. (Filer) CIK: 0001621221 (see all company filings)

EIN.: 331220924 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38951 | Film No.: 25937317
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)